Eosinopenia predicts poor outcomes in patients with lung cancer with the omicron variant of COVID-19

Eosinopenia predicts poor outcomes in patients with lung cancer with the omicron variant of COVID-19

BackgroundLung cancer is among the malignancies most vulnerable to coronavirus disease 2019 (COVID-19). Eosinophils have anti-tumor and antiviral effects. Since November 2021, the omicron variant of COVID-19 has become a topic of concern; however, the impact of eosinophils on the severity and outcom...

Full description

Saved in:
Bibliographic Details
Main Authors: Xiao Hu, Jie Tan, Rumei Luan, Dongyan Ding, Ming Yue, Junling Yang, Qianfei Xue
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-07-01
Series:Frontiers in Medicine
Subjects:
omicron
COVID-19
lung cancer
eosinopenia
outcomes
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2025.1583843/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items